Note: Ingredients listed on restricted chemical lists
EC/CAS
54068-28-9
Name of the chemical
Dioctylbis(pentane-2,4-dionato-O,O')tin
Concentration
10-25%
EC/CAS
68299-15-0
Name of the chemical
Dioctyltindineodecanoate
Concentration
≥2.5-<10%
EC/CAS
201-083-8/78-10-4
Name of the chemical
Tetraethyl orthosilicate
Concentration
1-2.5%
EC/CAS
203-905-0/111-76-2
Name of the chemical
Ethylene glycol monobutyl ether (EGBE)
Concentration
0.1-1%
General Information
Version
6
Revision date
2024-07-10
Product name
Omnident Pastenhärter Labor
1.2.1 Relevant identified uses
technical activator for C-silicones
Emergency telephone
+49 (0) 6106 - 874 - 0
Icons in SDS
Company Information
company name
Omnident Dental-Handelsgesellschaft mbH
e-mail address of the competent person responsible for the Safety Data Sheet
info@omnident.de
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H315, H317, H371, H373
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture
Hazard pictograms
GHS07 GHS08
Hazardous Ingredients
Dioctylzinnbisacetylacetonate (CAS 54068-28-9) Tetrakis(2-butoxyethoxy)silane (CAS 18765-38-3)
Hazard statements
H315 Causes skin irritation. H317 May cause an allergic skin reaction. (Contd. on page 2) EU (Contd. of page 1) H371 May cause damage to the immune system. Route of exposure: Oral. H373 May cause damage to the blood through prolonged or repeated exposure. Route of exposure: Oral.
Precautionary statements
P101 If medical advice is needed, have product container or label at hand. P102 Keep out of reach of children. P103 Read carefully and follow all instructions. P260 Do not breathe dust/fume/gas/mist/vapours/spray. P280 Wear protective gloves. P333+P313 If skin irritation or rash occurs: Get medical advice/attention. P321 Specific treatment (see on this label). P405 Store locked up. P501 Dispose of contents/container in accordance with local/regional/national/international regulations.
Additional information
Restricted to professional users
Results of PBT and vPvB assessment
This substance/mixture does not contain components classified as either persistent, bioaccumulative and toxic (PBT) or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
PBT Substances
Not applicable
vPvB Substances
Not applicable - Determination of endocrine-disrupting properties Endocrine disrupting properties - human health: The substance/mixture does not contain any components that exhibit endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated Regulation (EU) 2017/2100 or Commission Delegated Regulation (EU) 2018/605 in quantities of 0.1% or more. Endocrine disrupting properties - Environment: The substance/mixture does not contain any components that exhibit endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated Regulation (EU) 2017/2100 or Commission Delegated Regulation (EU) 2018/605 in quantities of 0.1% or more. *
2.1 Classification of the substance or mixture
- Classification according to Regulation (EC) No 1272/2008 GHS08 health hazard STOT SE 2 H371 May cause damage to the immune system. Route of exposure: Oral. STOT RE 2 H373 May cause damage to the blood through prolonged or repeated exposure. Route of exposure: Oral. GHS07 Skin Irrit. 2 H315 Causes skin irritation. Skin Sens. 1 H317 May cause an allergic skin reaction.
